Japan's recent economic recession has not slowed the great demand for technologically innovative products that are flooding the Western medical markets. The country's aging population and the government's efforts at deregulating the distribution process are some of the main factors pushing Japan's... Read More
As South Korea's economy rebounds from the Asian financial crisis, its pharmaceutical and medical device markets are also rebounding due to increased demand and consumption. Part of the Korean government's economic reforms include the deregulation of its markets and promoting of foreign... Read More
Thanks to significant government reform efforts since 1998, the Malaysian economy has been able to rebound from the Asian currency crisis of 1997. The costs of healthcare in Malaysia are on the rise and the government is looking to cut healthcare expenditure,... Read More
Despite the harsh effects of the Asian financial crisis, pharmaceutical markets in Asia still have a bright future. Thailand’s pharmaceutical market suffered drops in 1997 and 1998 but renewed consumer demand and increased incomes are helping rebound the Thai pharmaceutical market growth... Read More
This article discusses some of the major issues facing foreign pharmaceutical companies looking to invest in the Indian market. India's pharmaceutical sector continues to grow at an annual rate of 15%-20%, and currently its pharmaceutical market is ninth in the world. Despite... Read More
Japan's $48 billion market for pharmaceuticals is the largest in the world behind the US, with about 19% of the global market. Ninety percent of the market, however, is dominated by domestic production. Imports account for less than 10% of the total... Read More
As of 1995, U.S. medical manufacturers held about 40% of Taiwan’s import market and that number will continue increase as Taiwan expands its medical technology market. Currently, the Department of Health (DOH) oversees all national health policies, formulates new programs, and manages... Read More
As China's standards of living steadily improves and healthcare access progresses, foreign manufacturers will have ample opportunities to invest in China's growing medical device market. Recent regulatory reforms and market adjustments have greatly improved the medical device regulation procedures. This article highlights... Read More
This paper provides an introduction to the basic differences between the U.S. and Japanese patent systems and the problems that arise for U.S. medical products companies operating under the Japanese system. Read More
In 1995, the Japanese spent $290 billon, or about 7% of their national income, on healthcare. In return for this investment, Japan boasts the world’s longest life-spans and universal health insurance. It has recently become easier for foreign medical companies to penetrate... Read More